245 related articles for article (PubMed ID: 17992593)
1. Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.
Voulgarelis M; Skopouli FN
Clin Rev Allergy Immunol; 2007 Jun; 32(3):265-74. PubMed ID: 17992593
[TBL] [Abstract][Full Text] [Related]
2. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
[TBL] [Abstract][Full Text] [Related]
3. [Lymphoproliferative disorders in Sjögren's syndrome].
Prochorec-Sobieszek M; Wagner T
Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
[TBL] [Abstract][Full Text] [Related]
4. Molecular B-cell clonality assay in minor salivary glands as a useful tool for the lymphoma risk assessment in Sjögren's syndrome.
Benyamine A; Poulet A; Belenotti P; Nihous H; Ene N; Jarrot PA; Swiader L; Mancini J; Beaufils N; Essaydi A; Gabert J; Weiller PJ; Kaplanski G
Joint Bone Spine; 2024 May; 91(3):105686. PubMed ID: 38161050
[TBL] [Abstract][Full Text] [Related]
5. Update on Sjögren's syndrome autoimmune epithelitis: from classification to increased neoplasias.
Tzioufas AG; Voulgarelis M
Best Pract Res Clin Rheumatol; 2007 Dec; 21(6):989-1010. PubMed ID: 18068857
[TBL] [Abstract][Full Text] [Related]
6. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
Le Guern V; Mouthon L
Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
[TBL] [Abstract][Full Text] [Related]
7. [Clonal B-cell reaction in Sjögren disease and Hashimoto autoimmune thyroiditis].
Tiemann M; Asbeck R; Wacker HH
Pathologe; 1996 Jul; 17(4):289-95. PubMed ID: 8927595
[TBL] [Abstract][Full Text] [Related]
8. Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
Mariette X
Leuk Lymphoma; 1999 Mar; 33(1-2):93-9. PubMed ID: 10194125
[TBL] [Abstract][Full Text] [Related]
9. [Gougerot-Sjögren syndrome and malignant lymphoproliferative syndromes].
Grosbois B; Jego P; Leblay R
Rev Med Interne; 1998 May; 19(5):319-24. PubMed ID: 9775165
[TBL] [Abstract][Full Text] [Related]
10. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
[TBL] [Abstract][Full Text] [Related]
11. Lymphoproliferation in autoimmunity and Sjögren's syndrome.
Voulgarelis M; Moutsopoulos HM
Curr Rheumatol Rep; 2003 Aug; 5(4):317-23. PubMed ID: 14531960
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.
Anaya JM; McGuff HS; Banks PM; Talal N
Semin Arthritis Rheum; 1996 Apr; 25(5):337-46. PubMed ID: 8778989
[TBL] [Abstract][Full Text] [Related]
13. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome.
Voulgarelis M; Ziakas PD; Papageorgiou A; Baimpa E; Tzioufas AG; Moutsopoulos HM
Medicine (Baltimore); 2012 Jan; 91(1):1-9. PubMed ID: 22198497
[TBL] [Abstract][Full Text] [Related]
14. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
[TBL] [Abstract][Full Text] [Related]
15. Mucosa-associated lymphoid tissue lymphoma in Sjögren's syndrome: risks, management, and prognosis.
Voulgarelis M; Moutsopoulos HM
Rheum Dis Clin North Am; 2008 Nov; 34(4):921-33, viii. PubMed ID: 18984412
[TBL] [Abstract][Full Text] [Related]
16. Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome.
Nocturne G; Virone A; Ng WF; Le Guern V; Hachulla E; Cornec D; Daien C; Vittecoq O; Bienvenu B; Marcelli C; Wendling D; Amoura Z; Dhote R; Lavigne C; Fior R; Gottenberg JE; Seror R; Mariette X
Arthritis Rheumatol; 2016 Apr; 68(4):977-85. PubMed ID: 26606524
[TBL] [Abstract][Full Text] [Related]
17. Malignant lymphoma in primary Sjögren's syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjögren's Syndrome.
Voulgarelis M; Dafni UG; Isenberg DA; Moutsopoulos HM
Arthritis Rheum; 1999 Aug; 42(8):1765-72. PubMed ID: 10446879
[TBL] [Abstract][Full Text] [Related]
18. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin gene rearrangements in lymphoplasmacytic infiltrates of labial salivary glands in Sjögren's syndrome. A possible predictor of lymphoma development.
Jordan R; Diss TC; Lench NJ; Isaacson PG; Speight PM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1995 Jun; 79(6):723-9. PubMed ID: 7621030
[TBL] [Abstract][Full Text] [Related]
20. Clinical features distinguishing lymphoma development in primary Sjögren's Syndrome--a retrospective cohort study.
Risselada AP; Kruize AA; Bijlsma JW
Semin Arthritis Rheum; 2013 Oct; 43(2):171-7. PubMed ID: 23664530
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
